Biocortech

Biocortech is a biopharmaceutical company committed to the discovery and development of novel biomarkers as predictive toxicogenomic assays, in vitro diagnostic tests and drug companion tests for psychiatric disorders such as depression, bipolar disorders, schizophrenia, suicidality and cognitive deficits. Biocortech’s proprietary technologies and assays enable drug candidate optimization, with respect to safety at the level of the central nervous system, as well as patient stratification and treatments monitoring in clinical setting.